Skip to main content
. 2017 May 2;6(5):e005231. doi: 10.1161/JAHA.116.005231

Table 4.

Hazard Ratios Relating HF Outcome to Risk Factors, Including Classes of Antihypertensive Treatment

Study Population (Health ABC, PREDICTOR, PROSPER)
Risk Factor Hazard Ratio 95% CI P Value
Female 0.87 0.71–1.05 0.15
Age, per y 1.08 1.05–1.11 <0.0001
BMI, kg/m2 1.03 1.01–1.05 0.007
Smoking (0,1) 1.84 1.46–2.32 <0.0001
Diabetes mellitus (0,1) 1.36 1.07–1.72 0.012
History of coronary artery disease (0,1) 2.52 2.08–3.06 <0.0001
Use of β‐blockers (0,1) 1.03 0.81–1.30 0.84
Use of RAAS inhibitors (0,1) 1.55 1.27–1.90 <0.0001
Use of vasodilators (0,1) 1.35 1.13–1.67 0.003
Use of diuretics (0,1) 1.37 1.13–1.67 0.002
Systolic blood pressure, per mm Hg 1.009 1.005–1.013 <0.0001
Heart rate, per beats per min 1.02 1.01–1.03 <0.0001
Serum creatinine, per μmol/L 1.005 1.004–1.006 <0.0001

Hazard ratios are expressed per 1‐unit increase in continuous risk factors. All analyses are corrected for study; the analysis in the patient cohort was further corrected for randomization group. Health ABC indicates Health Aging and Body Composition; HF, heart failure; PREDICTOR, Valutazione della PREvalenza di DIsfunzione Cardiaca asinTOmatica e di scompenso cardiac; PROSPER, Prospective Study of Pravastatin in the Elderly at Risk; RAAS, renin‐angiotensin‐aldosterone system.